Takeda Wins Shareholder Approval for $62 Billion Shire Deal

(Bloomberg) -- Takeda Pharmaceutical Co. received shareholder approval for its $62 billion acquisition of U.K.-listed Shire Plc, an endorsement of Chief Executive Officer Christophe Weber’s strateg...

Bloomberg Quint

Add BloombergQuint App to Home screen.